Bodisen Sets Record Revenue Growth
Bodisen Biotech Reports Record Earnings Per Share of $0.56 in 2005, Net Income Up 75%, Revenues Up 91%
2005 FINANCIAL HIGHLIGHTS
- Revenues grew 91% to approximately $31.0 million from $16.2 million in 2004.
- Gross Profit increased to $11.5 million, from $6.6 million for the prior year.
- Comprehensive Income of $11.9 million, up 133% from same period in 2004.
- Net Income, prior to one time financing related accounting charges of approximately $1.4 million, grew 75% to approximately $8.8 million, or $0.56 per fully diluted share, compared with net income of $5.0 million, or $0.33 per fully diluted share for 2004.
